Email Alert RSS
Volume 11 Issue 1
Jan.  2020
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2020  >  11(1): 73-78
Miao MA, Rui-yi TANG, Rong CHEN. Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182
Citation: Miao MA, Rui-yi TANG, Rong CHEN. Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 73-78. doi: 10.3969/j.issn.1674-9081.20170182
shu

Management of Unscheduled Bleeding in Women Using Combined Oral Contraceptives

doi: 10.3969/j.issn.1674-9081.20170182
  • 1.

    Gynecological Endocrinology and Reproductive Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • 2.

    Department of Obstetrics & Gynecology, Obstetrics & Gynecology Hospital of Fudan University, Shanghai 200011, China

More Information
  • Corresponding author: CHEN Rong Tel: 86-10-69155012, E-mail:chenrongpumch@163.com
  • Received Date: 2017-08-25
  • Publish Date: 2020-01-30
    Abstract
  • Unscheduled bleeding is a common cause of discontinuation during the using of combined oral contraceptives(COC). Compliance can be improved by appropriate counseling about the possibility of unscheduled bleeding, as well as by the necessary prevention and treatment. The mechanisms underlying this kind of bleeding are not fully understood. There is little high-level evidence of clinical strategies to support the management of unscheduled bleeding associated with COC. It is critical to role out gynecological pathology for patients with persistent or new-onset unscheduled bleeding.
    • FullText(HTML)
  • loading
    • References(31)
  • [1] 复方口服避孕药临床应用中国专家共识专家组.复方口服避孕药临床应用中国专家共识[J].中华妇产科杂志, 2015, 50:81-91. http://d.wanfangdata.com.cn/periodical/zhfck201502001
    [2] Maguire K, Westhoff C. The state of hormonal contraception today:established and emerging noncontraceptive health benefits[J]. Am J Obstet Gynecol, 2011, 205:S4-S8. doi:  10.1016/j.ajog.2011.06.056
    [3] 中华医学会妇产科学分会绝经学组.围绝经期异常子宫出血诊断和治疗专家共识[J].协和医学杂志, 2018, 9:313-319. http://oldmed.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_zhfck201806007
    [4] Shlomo M, Kenneth S, Polonsky P, et al. Williams Textbook of Endocrinology[M]. 13th ed. Amsterdam:Elsevier, 2015:664-693.
    [5] Reid RL, Fortier MP, Smith L, et al. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada[J]. Contraception, 2010, 82:497-502. doi:  10.1016/j.contraception.2010.06.002
    [6] Mishell DR Jr, Guillebaud J, Westhoff C, et al. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials[J]. Contraception, 2007, 75:11-15. doi:  10.1016/j.contraception.2006.08.012
    [7] Lumsden MA, Gebbie A, Holland C. Managing unscheduled bleeding in non-pregnant premenopausal women[J]. BMJ (Online), 2013, 346:f3251 https://www.bmj.com/content/346/bmj.f3251.full
    [8] Galant C, Berliere M, Dubois D, et al. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding[J]. Am J Pathol, 2004, 165:83-94. doi:  10.1016/S0002-9440(10)63277-4
    [9] Vincent AJ, Zhang J, Ostor A, et al. Matrix metalloproteinase-1 and-3 and mast cells are present in the endometrium of women using progestin-only contraceptives[J]. Hum Reprod, 2000, 15:123-130. doi:  10.1093/humrep/15.1.123
    [10] Hickey M, Fraser IS. Clinical implications of disturbances of uterine vascular morphology and function[J]. Baillieres Best Pract Res Clin Obstet Gynaecol, 2000, 14:937-951. doi:  10.1053/beog.2000.0136
    [11] Endrikat J, Gerlinger C, Plettig K, et al. A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive use[J]. Gynecol Endocrinol, 2003, 17:107-114. doi:  10.1080/gye.17.2.107.114
    [12] Dickinson BD, Altman RD, Nielsen NH, et al. Drug interactions between oral contraceptives and antibiotics[J]. Obstet Gynecol, 2001, 98:853-860.
    [13] Rosenberg MJ, Waugh MS, Stevens CM. Smoking and cycle control among oral contraceptive users[J]. Am J Obstet Gynecol, 1996, 174:628-632. doi:  10.1016/S0002-9378(96)70440-4
    [14] FSRH. Management of Unscheduled Bleeding in Women Using Hormonal Contraception[M/OL]. UK: Faculty of Sexual and Reproductive Healthcare Clinical Effectiveness Unit, 2009: 1-19. https://www.rcog.org.uk/globalassets/documents/guidelines/unscheduledbleeding23092009.pdf.
    [15] CDC. Sexually Transmitted Disease Surveillance 2016[M/OL]. US: Centers for Disease Control and Prevention, 2016.https://www.cdc.gov/std/stats16/CDC_2016_STDS_Report-for508WebSep21_2017_1644.pdf.
    [16] Chen XS, Peeling RW, Yin YP, et al. The epidemic of sexually transmitted infections in China:implications for control and future perspectives[J]. BMC Med, 2011, 9:111. doi:  10.1186/1741-7015-9-111
    [17] Speroff L, Darney PD. A Clinical Guide For Contraception[M].5th ed. US:Lippincott Williams & Wilkins, 2010.
    [18] Hickey M, Agarwal S. Unscheduled bleeding in combined oral contraceptive users:focus on extended-cycle and continuous-use regimens[J]. J Fam Plann Reprod Health Care, 2009, 35:245-248. doi:  10.1783/147118909789587411
    [19] Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC) US. Selected Practice Recommendations for Contraceptive Use, 2013:adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition[J]. MMWR Recomm Rep, 2013, 62:1-60.
    [20] Kaunitz A, Howard B, Weiss H, et al. Bleeding profile of a novel ascending-dose, extended-regimen ethinyl estradiol/levonorgestrel combination oral contraceptive (OC)[J]. Contraception, 2013, 88:311-312.
    [21] Gallo MF, Nanda K, Grimes DA, et al. 20μg versus >20μg estrogen combined oral contraceptives for contraception[J]. Cochrane Database Syst Rev, 2013, (8):CD003989.
    [22] Edelman AB, Koontz SL, Nichols MD, et al. Continuous oral contraceptives:are bleeding patterns dependent on the hormones given?[J]. Obstet Gynecol, 2006, 107:657-665. doi:  10.1097/01.AOG.0000199950.64545.16
    [23] Sulak PJ, Kuehl TJ, Coffee A, et al. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen[J]. Am J Obstet Gynecol, 2006, 195:935-941. doi:  10.1016/j.ajog.2006.02.048
    [24] Kaneshiro B, Edelman A, Carlson N, et al. Treatment of unscheduled bleeding in continuous oral contraceptive users with doxycycline:a randomized controlled trial[J]. Obstet Gynecol, 2010, 115:1141-1149. doi:  10.1097/AOG.0b013e3181e0119c
    [25] Kaneshiro B, Edelman A, Carlson NE, et al. Unscheduled bleeding with continuous oral contraceptive pills:a compari-son of progestin dose[J]. Contraception, 2012, 86:22-27. doi:  10.1016/j.contraception.2011.11.003
    [26] Apter D, Zimmerman Y, Beekman L, et al. Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives:Results from a phase Ⅱ, randomised, dose-finding study (FIESTA)[J]. Contraception, 2016, 94:366-373. doi:  10.1016/j.contraception.2016.04.015
    [27] Lawrie TA, Helmerhorst FM, Maitra NK, et al. Types of progestogens in combined oral contraception:effectiveness and side-effects[J]. Cochrane Database Syst Rev, 2011, (5):CD004861.
    [28] Van Vliet HA, Grimes DA, Helmerhorst FM, et al. Bipha-sic versus monophasic oral contraceptives for contraception:a Cochrane review[J]. Hum Reprod, 2002, 17:870-873. doi:  10.1093/humrep/17.4.870
    [29] Van Vliet HA, Grimes DA, Helmerhorst FM, et al. Bipha-sic versus triphasic oral contraceptives for contraception[J]. Cochrane Database Syst Rev, 2006, (3):CD003283. https://www.ncbi.nlm.nih.gov/pubmed/12057781/
    [30] Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive[J]. Contraception, 2003, 68:89-96. doi:  10.1016/S0010-7824(03)00141-0
    [31] Wiegratz I, Stahlberg S, Manthey T, et al. Effect of extended-cycle regimen with an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on bleeding patterns, safety, acceptance and contraceptive efficacy[J]. Contraception, 2011, 84:133-143. doi:  10.1016/j.contraception.2011.01.002
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (639) PDF downloads(170) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return